These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33793366)

  • 1. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
    Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
    Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
    Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
    Konishi M
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
    Nakachi K; Gotohda N; Hatano E; Nara S; Takahashi S; Kawamoto Y; Ueno M
    Jpn J Clin Oncol; 2023 Nov; 53(11):1019-1026. PubMed ID: 37599063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant treatment in biliary tract cancer: to treat or not to treat?
    Cereda S; Belli C; Reni M
    World J Gastroenterol; 2012 Jun; 18(21):2591-6. PubMed ID: 22690066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
    Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
    J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary tract: Is there a role for neoadjuvant and adjuvant therapy in biliary cancer?
    Jarnagin WR
    Nat Rev Gastroenterol Hepatol; 2012 Nov; 9(11):622-3. PubMed ID: 23007479
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant therapy for resected biliary tract cancer: a review.
    Doherty MK; Knox JJ
    Chin Clin Oncol; 2016 Oct; 5(5):64. PubMed ID: 27701873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant treatments for biliary tract cancer.
    Furuse J
    J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy trials in biliary tract malignancies.
    Medin CR; Maithel SK
    J Surg Oncol; 2022 Jan; 125(1):84-88. PubMed ID: 34897705
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
    Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
    Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapy and future directions in biliary tract malignancies.
    Ciombor KK; Goff LW
    Curr Treat Options Oncol; 2013 Sep; 14(3):337-49. PubMed ID: 23686724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality Management of Localized Biliary Cancer.
    Ashai N; Prasad P; Rajdev L
    Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of adjuvant therapy for biliary tract cancer].
    Kato A; Miyazaki M
    Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
    Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
    Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
    Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
    Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.